A 52-year-old woman with obstructive jaundice was diagnosed as advanced duodenal cancer with distant lymph node metastasis and early rectal cancer based on computed tomography (CT) and gastrointestinal series. We performed pancreaticoduodenectomy with D3 lymph node dissection. Metastatic lymph node tissue was submitted to chemosensitivity test. Based on the chemosensitivity test, FOLFOX (Leucovorin + 5-FU + Oxaliplatin) was administered intravenously. The patient received 3 cycles of FOLFOX chemotherapy until appearance of grade 4 leucopenia and grade 3 vomiting. After the FOLFOX, she received 12 cycles of TS-1 + CDDP chemotherapy without serious complications. She remained well without any symptoms and pursued normal activity for 27 month...
A 56-year-old Japanese woman who underwent a curative resection of ascending colon cancer at 43 year...
A case of advanced rectal cancer treated by aggressive local and systemic treatment who has survived...
Background: Colorectal adenocarcinoma, the third most diagnosed cancer in males and the second most ...
A 52-year-old woman with obstructive jaundice was diagnosed as advanced duodenal cancer with distant...
A 50-year-old female became aware of skin yellowing and consulted another hospital where she was dia...
Treatment of duodenal malignant lymphoma is difficult due to life-threatening complications such as ...
Hypothesis: Adjuvant chemoradiation improves local control and survival in patients with node-positi...
A 55-year-old man who had been diagnosed with rectal cancer with multiple liver metastases and lymp...
BACKGROUND: Patients (pts) with metastatic rectal cancer and symptomatic primary, require local and ...
Abstract Background Primary duodenal adenocarcinoma (PDC) is a rare and lethal disease, and cases wi...
Introduction: FOLFOX and panitumumab combined chemotherapy plays an important role for metastatic co...
A 63-year-old woman was admitted to our institution for severe pain in her right lower abdomen cause...
Introduction: Recent approval and introduction into clinical practice of epidermal growth factor rec...
Anal canal adenocarcinoma is a relatively rare malignancy without established diagnostic and treatme...
We report the case of a 38-year-old female who was diagnosed as advanced gastric cancer with lymph n...
A 56-year-old Japanese woman who underwent a curative resection of ascending colon cancer at 43 year...
A case of advanced rectal cancer treated by aggressive local and systemic treatment who has survived...
Background: Colorectal adenocarcinoma, the third most diagnosed cancer in males and the second most ...
A 52-year-old woman with obstructive jaundice was diagnosed as advanced duodenal cancer with distant...
A 50-year-old female became aware of skin yellowing and consulted another hospital where she was dia...
Treatment of duodenal malignant lymphoma is difficult due to life-threatening complications such as ...
Hypothesis: Adjuvant chemoradiation improves local control and survival in patients with node-positi...
A 55-year-old man who had been diagnosed with rectal cancer with multiple liver metastases and lymp...
BACKGROUND: Patients (pts) with metastatic rectal cancer and symptomatic primary, require local and ...
Abstract Background Primary duodenal adenocarcinoma (PDC) is a rare and lethal disease, and cases wi...
Introduction: FOLFOX and panitumumab combined chemotherapy plays an important role for metastatic co...
A 63-year-old woman was admitted to our institution for severe pain in her right lower abdomen cause...
Introduction: Recent approval and introduction into clinical practice of epidermal growth factor rec...
Anal canal adenocarcinoma is a relatively rare malignancy without established diagnostic and treatme...
We report the case of a 38-year-old female who was diagnosed as advanced gastric cancer with lymph n...
A 56-year-old Japanese woman who underwent a curative resection of ascending colon cancer at 43 year...
A case of advanced rectal cancer treated by aggressive local and systemic treatment who has survived...
Background: Colorectal adenocarcinoma, the third most diagnosed cancer in males and the second most ...